Nyxoah S.A.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Nyxoah S.A.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Frequently asked questions
To buy Nyxoah S.A. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Nyxoah S.A. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Nyxoah S.A. is NYXH:xbru. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Nyxoah S.A. has its primary listing on Euronext Brussels. You can trade Nyxoah S.A. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nyxoah S.A. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Nyxoah S.A. as part of a broader investment portfolio.